PEPG

NASD PepGen Inc.
Nov 16, 2026 · 5:37 PM ET LAST TRADE Market Closed

$4.15 ↓ -0.04 (-0.95%) Trading Down from the previous close of $4.19, $0.19 below the day’s high of $4.34

YTD change
-36.25%
vs 20-day SMA
+39.24%
vs 200-day SMA
+41.50%

Price ranges

Previous day
$4.34 $5.08
open $5.05 close $4.36
-$0.69 (-13.66%)
Today
$4.10 $4.34
open $4.25 now $4.15
-$0.10 (-2.35%)
Past week
$2.28 $6.45
from $2.47 now $4.15
+$1.68 (+68.02%)
Past month
$2.22 $6.45
from $2.60 now $4.15
+$1.55 (+59.62%)
This year
$1.31 $7.80
from $6.51 now $4.15
-$2.36 (-36.25%)

Price & Performance

+2.89 (+196.60%) / 6M

$1.04$2.55$4.06$5.57May 18Aug 17Nov 13

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 79.2% away from all-time highs of $20.00
  • PEPG is down 36% since the beginning of the year
  • PEPG is down 12% over the past 12 months
  • PEPG is up 60% over the past 1 month
  • 5% of all PEPG investors are betting against PEPG

PEPG reads not so good: price sits above both the 20- and 200-day averages, the 12-month move is -18.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.28
Earnings momentum +7.1% Quarterly EPS growth
Quarterly change +7.1%

Valuation

P/E ratio N/A
Enterprise value $212.8M
Beta 2.75

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$104.8M
Debt$15.6K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $391.2M

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded on November 9, 2020 and is headquartered in Boston, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $465.67 -0.30%
MRNA Moderna, Inc. $223.37 -3.45%
RVMD Revolution Medicines, Inc. $172.29 -2.30%
ROIV Roivant Sciences Ltd. $39.53 -1.15%
BNTX BioNTech SE Sponsored ADR $85.60 +0.66%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.